VEGFR Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 5318 | AEE 788 |
| Potent VEGFR and EGFR inhibitor | |
| 4274 | AP 24534 |
| Potent multi-kinase and pan-Bcr-Abl inhibitor | |
| 4350 | Axitinib |
| Potent VEGFR-1, -2 and -3 inhibitor | |
| 7454 | Cediranib |
| Potent inhibitor of VEGFR, PDGFR and FGFR | |
| 2542 | Ki 8751 |
| Potent, selective VEGFR-2 inhibitor | |
| 7743 | Linifanib |
| Potent inhibitor of PDGFRβ, KDR, FLT3 and CSF-1R | |
| 7049 | Nintedanib |
| Potent VEGFR, PDGFR and FGFR inhibitor | |
| 6814 | Sorafenib |
| VEGFR-2 and VEGFR-3 inhibitor; also inhibits Raf-1, PDGFR-β, Flt-3 and cKIT | |
| 3300 | SU 5402 |
| Potent VEGFR and FGFR inhibitor | |
| 3037 | SU 5416 |
| VEGFR inhibitor. Also inhibits KIT, RET, MET and FLT3 | |
| 3768 | Sunitinib malate |
| Potent VEGFR, PDGFRβ and KIT inhibitor | |
| 7497 | Vandetanib |
| Potent VEGFR-2 inhibitor, also inhibits EGFR and RET oncoproteins activity | |
| 5680 | Vatalanib succinate |
| Potent VEGFR inhibitor; also aromatase inhibitor | |
| 5422 | XL 184 |
| Potent VEGFR inhibitor; also inhibits other RTKs | |
| 2475 | ZM 323881 hydrochloride |
| Potent, selective inhibitor of VEGFR-2 |
Angiogenesis in Cancer Life Science Poster
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDF